Cite
APA Citation
Rao, I. R., Pinnamaneni, S. T., Ranjana, M., Ritambhra, N., Vivek, K., Manish, R., Kohli, H. S., Jha, V. V., Gupta, K., & Raja, R. (2017). rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome. Nephrology, 22(9), 731–732. http://access.bl.uk/ark:/81055/vdc_100048105431.0x00002d